What are the Causes of Congenital Adrenal Hyperplasia (CAH)? Congenital Adrenal Hyperplasia (CAH) is caused by the deficiency of steroid hormone synthesizing enzymes, which occur due to mutations in ...

How can you Treat Congenital Adrenal Hyperplasia (CAH)? Treatment options can vary between individuals and depend on several factors including type of CAH and the associated symptoms and signs. In ...

Disorders/differences of sex development (DSD) are difficult to diagnose because of the multiple phenotypes and genes involved, but a new technique developed at Hudson Institute of Medical Research is ...

Congenital adrenal hyperplasia can be effectively treated with glucocorticoids. However, to prevent undertreatment, which causes androgen excess, and overtreatment, which poses the risk of iatrogenic ...

CAH is a condition in which a gene that tells the body how to make an enzyme called 21-hydroxylase, which helps make cortisol and aldosterone, doesn't work properly. For you to have CAH, both of your ...

The treatments for both classic and nonclassic congenital adrenal hyperplasia (CAH) include medication, surgery, and psychological support, or a combination of all three. Some people who have CAH, ...

Congenital adrenal hyperplasia is usually treated with steroid hormones, but these can inhibit growth when administered at high doses, especially during early to mid-adolescence. A retrospective ...

Neurocrine Biosciences has announced that the US Food and Drug Administration (FDA) has accepted its two New Drug Applications (NDA) for crinecerfont, granting them Priority Review designations. The ...

A 29-year-old man was seen 2 years ago to transfer his care from pediatric to adult endocrinology. He was diagnosed at birth with classic congenital adrenal hyperplasia from 21-hydroxylase deficiency ...

Neurocrine Biosciences’ newest educational campaign wants frustrated congenital adrenal hyperplasia patients to ask, “What the C@H?!” Neurocrine unveiled the campaign this week, not long after ...

Newark, New Castle, USA, June 22, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the market size of the global congenital adrenal hyperplasia treatment in 2022 to be worth US$ 27.03 million, ...

Nonclassical congenital adrenal hyperplasia (NCAH) can lead to the production of excess male hormones. It is usually a mild condition and often doesn’t need to be treated. Nonclassical congenital ...